Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules

Molecular testing for risk stratification of thyroid nodules is covered when performed according to MolDX LCD L39650 (typically for indeterminate thyroid nodule pathology). The test is generally limited to one lifetime performance per patient, although a second unrelated indeterminate nodule may be considered with supporting documentation; claims must include the appropriate CPT, one unit of service, ICD-10-CM diagnosis, and the DEX Z-Code entered in the specified claim fields (with no extra characters on SV101-7).

"Molecular testing for risk stratification of thyroid nodules is covered when performed in accordance with the MolDX Local Coverage Determination L39650 (i."

Sign up to see full coverage criteria, indications, and limitations.